Phase Ia/Ib clinical study on the safety, tolerability and preliminary efficacy of SG12473 for injection in patients with advanced malignant tumors
Latest Information Update: 25 Oct 2024
At a glance
- Drugs SG 301 (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions
- 25 Sep 2023 New trial record